| ALXO Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the ALXO shares outstanding history going back to 7/17/2020:
Also see: ALXO Market Cap History ALXO YTD Return |
As of 5/1/2026 ALX Oncology Holdings has 134.56 million ALXO shares outstanding. Investors often track the ALXO shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows ALXO share count trends over time, with 25 historical shares outstanding datapoints presented, dating back to 7/17/2020.

| ALXO Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the ALXO shares outstanding history going back to 7/17/2020:
Also see: ALXO Market Cap History ALXO YTD Return |
| ALXO Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||
ALXO Historical Shares Outstanding: +26.36% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| ALXO Stock Price Chart |
| About ALX Oncology Holdings Inc |
| ALX Oncology Holdings Inc. is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 immune checkpoint inhibitor and bridge the innate and adaptive immune system. Its product candidate, evorpacept, is a CD47 blocking therapeutic that combines a high-affinity CD47 binding domain with an inactivated, proprietary Fc domain. It is engaged in focusing on combining evorpacept with anti-cancer antibodies, ADCs, and PD-1/PD-L1 immune checkpoint inhibitors. We show 25 historical shares outstanding datapoints in our coverage of ALXO's shares outstanding history. Understanding the changing numbers of ALXO shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ALXO versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ALXO by allowing them to research ALXO shares outstanding history as well as any other stock in our coverage universe. |
| ALXO Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| ALXO Share Performance |
| Shares Outstanding Peers |
| ALX Oncology Holdings (ALXO) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
ALZN Shares Outstanding History AMAG Shares Outstanding History AMAM Shares Outstanding History AMDA Shares Outstanding History AMED Shares Outstanding History AMEH Shares Outstanding History AMGN Shares Outstanding History AMIX Shares Outstanding History AMLX Shares Outstanding History AMN Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.